BeStock  
Stocks › Biotechnology › PHVS

Pharvaris PHVS

US equityMarket cap rank #2618Biotechnology
$31.28 −$0.38 (-1.20%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $31.28 0.00%
Open$31.41
Prev close$31.66
Day range$30.43 – $31.99
Volume464.0K
Market cap$2.21B
P/E (TTM)–
Dividend yield–

PHVS Stock News

Headlines matching Pharvaris or the PHVS ticker, most recent first.

  • Morgan Stanley Maintains Pharvaris(PHVS.US) With Buy Rating, Maintains Target Price $46Market news · 8 Sep 2026 · Direct mention
  • Form 144(Amend) | Pharvaris(PHVS.US) Officer Proposes to Sell 7 Million in Common StocksMarket news · 23 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains Pharvaris(PHVS.US) With Buy Rating, Maintains Target Price $60Market news · 22 Sep 2026 · Direct mention
  • Pharvaris (PHVS) Gets a Buy From H.C. WainwrightTipRanks · 22 Sep 2026 · Direct mention
  • Form 144 | Pharvaris(PHVS.US) Officer Proposes to Sell 3.5 Million in Common StocksMarket news · 18 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Pharvaris(PHVS.US), With a Forecast Between $44 to $79Market news · 10 Sep 2026 · Direct mention
  • JonesTrading Maintains Pharvaris(PHVS.US) With Buy Rating, Maintains Target Price $52Market news · 29 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Pharvaris(PHVS.US), With a Forecast Between $38 to $55Market news · 13 Aug 2026 · Direct mention
  • BofA Securities Maintains Pharvaris(PHVS.US) With Hold Rating, Raises Target Price to $35 PositiveMarket news · 29 Jul 2026 · Direct mention
  • Wells Fargo Initiates Pharvaris(PHVS.US) With Buy Rating, Announces Target Price $55Market news · 15 Jul 2026 · Direct mention
  • Morgan Stanley Maintains Pharvaris(PHVS.US) With Buy Rating, Raises Target Price to $46 PositiveMarket news · 25 Jun 2026 · Direct mention
  • Morgan Stanley Maintains Pharvaris(PHVS.US) With Buy Rating, Maintains Target Price $41Market news · 15 Jun 2026 · Direct mention
  • Morgan Stanley Maintains Pharvaris(PHVS.US) With Buy Rating, Cuts Target Price to $30.4 NegativeMarket news · 18 May 2026 · Direct mention
  • BofA Securities Maintains Pharvaris(PHVS.US) With Hold Rating, Raises Target Price to $33 PositiveMarket news · 14 May 2026 · Direct mention
  • A Quick Look at Today's Ratings for Pharvaris(PHVS.US), With a Forecast Between $46 to $74Market news · 13 May 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on PHVS.

Sign in to join the discussion.

Scroll to Top